Biochemistry, Genetics and Molecular Biology
Genetics
100%
Vitamin K Epoxide Reductase
63%
Pharmacogenetics
63%
Atrial Fibrillation
36%
Targeted Therapy
27%
Genomics
18%
Genetic Risk
18%
Drug Therapy
18%
Cytochrome P450
9%
Metabolic Pathway
9%
Oxidoreductase
9%
Isoform
9%
Prospective Study
9%
Carboxylation
9%
Pharmacogenomics
9%
Genetic Divergence
9%
Candidate Gene
9%
Reductase
9%
Human Study
9%
Structure Activity Relationship
9%
Dose Response
9%
Drug Interaction
9%
Enzyme
9%
Trastuzumab
9%
Drug Effect
9%
Blood Coagulation Factor
9%
Gene Interaction
9%
Pharmacology, Toxicology and Pharmaceutical Science
Warfarin
100%
Pharmacogenetics
32%
Vitamin K Epoxide Reductase
28%
Thromboembolism
20%
Anticoagulant Agent
16%
Atrial Fibrillation
16%
Therapeutic Window
8%
Pharmacotherapy
8%
Venous Thromboembolism
8%
Chronic Disease
8%
Genetic Risk
8%